RoActemra News
Most Popular RoActemra Story
EMEA approves sale of Roche's RA blockbuster
Roche has won final European approval to market RoActemra, a potential new blockbuster therapy for rheumatoid arthritis. Last month the FDA said it would need to examine additional data from animal Read more...
Latest Headlines
- January 21, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
